Fresenius Medical Care AG FMS
Set alert
At close · Oct 30
After hours · Oct 30, 5:47 PM ET
- YTD
- -5.67%
- 1 year
- -15.78%
- Open
- 22.82
- Prev close
- 23.13
- Mkt cap
- 11.96B
- Vol
- 967.97K
- Avg vol
- 923.86K
- EPS
- 1.94
- P/E
- 11.58
- Div yield
- 3.77%
More statistics
- Low
- 22.45
- High
- 22.89
- Forward P/E
- 7.55
- Beta
- 0.81
- Short ratio
- 4.08
- Inst. own
- 9.96%
- Dividend
- 0.87
- Ex-div date
- May 21, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 22.41
- 200-d avg
- 22.87
- 1y target
- 23.77
2Y chart
Events in this range
- Jan 6, 2025Rating: Truist Securities · Hold → Hold
- May 12, 2025Rating: Truist Securities · Hold → Hold
- May 23, 2025Dividend: 0.81497
- Aug 5, 2025Earnings: 0.52; estimate 0.5; surprise 4%
- Sep 2, 2025Downgrade: UBS · Neutral → Sell
- Nov 4, 2025Earnings: 0.64; estimate 0.59; surprise 8.47%
- Feb 24, 2026Earnings: 0.83; estimate 0.647; surprise 28.28%
- May 5, 2026Earnings: 0.53; estimate 0.59; surprise -10.17%
- May 22, 2026Dividend: 0.86435
- Aug 3, 2026Earnings: 0.66; estimate 0.616; surprise 7.14%
- Aug 6, 2026Rating: Bernstein · Market Perform → Market Perform
- Oct 12, 2026Rating: Truist Securities · Hold → Hold
Signals (97)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 2 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| RSI: Oversold | May 5, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 15, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 18, 2026 | 7 months ago |
| SMA: Bullish | Mar 17, 2026 | 7 months ago |
| SMA: Bearish | Mar 10, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| SMA: Bullish | Feb 4, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 7, 2026 | 9 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| RSI: Oversold | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Sep 26, 2025 | 1 year ago |
| SMA: Bullish | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| RSI: Oversold | Aug 5, 2025 | 1 year ago |
| SMA: Bearish | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| RSI: Overbought | May 15, 2025 | 1 year ago |
| RSI: Overbought | May 6, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| SMA: Bearish | Apr 17, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 17, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| SMA: Bullish | Mar 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 13, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 5, 2025 | 1 year ago |
| SMA: Bearish | Mar 4, 2025 | 1 year ago |
| SMA: Bullish | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| SMA: Bearish | Feb 14, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| RSI: Overbought | Jan 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 17, 2025 | 1 year ago |
| RSI: Overbought | Dec 2, 2024 | 1 year ago |
Key statistics
- Market cap
- 11.96B
- Enterprise value
- 23.20B
- Trailing P/E
- 11.58
- Forward P/E
- 7.55
- PEG ratio
- 0.77
- Price / sales
- 0.62
- Price / book
- 0.85
- EPS (TTM)
- 1.94
- Beta
- 0.81
- Dividend yield
- 3.77%
- Payout ratio
- 45.01%
- Profit margin
- 4.83%
- Revenue (TTM)
- 19.43B
- Revenue growth
- 1.40%
- Free cash flow
- 2.02B
- Total cash
- 1.06B
- Total debt
- 10.98B
- Return on equity
- 8.52%
- Shares outstanding
- 532.22M
- Short % of float
- 0.00%
- 50-day average
- 22.41
- 200-day average
- 22.87
Analyst view
Consensus: hold
- Target (low)
- 17.27
- Target (mean)
- 23.77
- Target (high)
- 37.78
- Strong buy0
- Buy1
- Hold3
- Sell1
- Strong sell2
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 0.529.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.651 | — | — | — |
| Aug 3, 2026 | Jun 30, 2026 | 0.616 | 0.66 | +0.04 | +7.14% |
| May 5, 2026 | Mar 31, 2026 | 0.59 | 0.53 | -0.06 | -10.17% |
| Feb 24, 2026 | Dec 31, 2025 | 0.647 | 0.83 | +0.18 | +28.28% |
| Nov 4, 2025 | Sep 30, 2025 | 0.59 | 0.64 | +0.05 | +8.47% |
| Aug 5, 2025 | Jun 30, 2025 | 0.50 | 0.52 | +0.02 | +4.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Truist Securities | main | Hold | Hold |
| Aug 6, 2026 | Bernstein | main | Market Perform | Market Perform |
| Sep 2, 2025 | UBS | down | Neutral | Sell |
| May 12, 2025 | Truist Securities | main | Hold | Hold |
| Jan 6, 2025 | Truist Securities | main | Hold | Hold |
| Oct 7, 2024 | Truist Securities | main | Hold | Hold |
About Fresenius Medical Care AG
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- Germany
- Website
- freseniusmedicalcare.com
News
- FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
- Reported Earlier, Fresenius Medical Care Launches multiFiltratePRO In US After FDA Clearance, Expanding Continuous Kidney Replacement Therapy Options For Acute Kidney Injury
- Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™
- Fly Alliance to Replace Entire Flight Management System with flyExclusive's AI-Powered Contrails FMS
- Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026
- Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24
- Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
- Fresenius Medical Care Appoints Shervin J. Korangy As CEO Effective October 12; Shervin J. Korangy To Succeed Helen Giza
- Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
- Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages
Your note
Sign in to keep a note on FMS — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pzena Investment Management LLC | 2.82% | 14,992,081 | 336.87M | Jun 29, 2026 |
| Morgan Stanley | 0.82% | 4,347,748 | 97.69M | Jun 29, 2026 |
| Dodge & Cox Inc. | 0.72% | 3,826,910 | 85.99M | Jun 29, 2026 |
| Fiduciary Management, Inc. | 0.55% | 2,937,829 | 66.01M | Jun 29, 2026 |
| Brandes Investment Partners L.P. | 0.36% | 1,916,090 | 43.05M | Jun 29, 2026 |
| Todd Asset Management LLC | 0.33% | 1,761,483 | 39.58M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD WINDSOR FUNDS-Vanguard Windsor Fund | 1.54% | 8,204,589 | 184.36M | Jul 30, 2026 |
| Dodge & Cox Funds-Dodge & Cox Balanced Fund | 0.72% | 3,826,910 | 85.99M | Jun 29, 2026 |
| VANGUARD WHITEHALL FUNDS-Vanguard Selected Value Fund | 0.48% | 2,539,431 | 57.06M | Jul 30, 2026 |
| Liberty All Star Equity Fund | 0.21% | 1,125,292 | 25.29M | Jun 29, 2026 |
| FMI Funds Inc-Large Cap Fund | 0.19% | 1,030,000 | 23.14M | Jun 29, 2026 |
| John Hancock Capital Series-Classic Value Fund | 0.16% | 874,362 | 19.65M | Aug 30, 2026 |